日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Pilot Study on the Safety and Adequacy of a Novel Ecofriendly Hemodialysis Prescription-Green Nephrology

一项关于新型环保血液透析处方安全性和充分性的试点研究——绿色肾脏病学

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2024.02.014
Solomon, Dolphin; Arumugam, Venkatesh; Sakthirajan, Ramanathan; Lamech, Tanuj Moses; Dineshkumar, Thanigachalam; Vathsalyan, Paulpandiyan; Senthilkumaran, Guhan; Krishna, Ravindran; Shaji, Sajmi; Gopalakrishnan, Natarajan
发表日期：2024
文献求助 收藏

Clinical Profile and Outcomes of Coronavirus Disease 2019 (COVID-19) in Patients Undergoing Hemodialysis

接受血液透析治疗的患者的冠状病毒病 2019 (COVID-19) 临床特征和预后

期刊:Indian Journal of Nephrology
影响因子:0.8
doi:10.4103/ijn.IJN_511_20
Lamech, Tanuj Moses; Nithya, Govindasamy; Aiswarya, Dhanapalan; Gopalakrishnan, Natarajan; Vathsalyan, Paulpandian; Sajmi, Shaji; Goutham, Kamalakannan; Krishna, Ravindran; Dineshkumar, Thanikachalam; Sakthirajan, Ramanathan; Dhanapriya, Jeyachandran; Padmaraj, Rajendran
微生物学
发表日期：2022
文献求助 收藏

Use of Remdesivir in Patients With COVID-19 on Hemodialysis: A Study of Safety and Tolerance

瑞德西韦在接受血液透析的新冠肺炎患者中的应用：一项安全性和耐受性研究

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2020.12.003
Aiswarya, Dhanapalan; Arumugam, Venkatesh; Dineshkumar, Thanigachalam; Gopalakrishnan, Natarajan; Lamech, Tanuj Moses; Nithya, Govindasamy; Sastry, Bhagavatula V R H; Vathsalyan, Paulpandian; Dhanapriya, Jeyachandran; Sakthirajan, Ramanathan
肺炎
新冠
微生物学
发表日期：2021
文献求助 收藏

Efficacy and safety of convalescent plasma therapy in SARS-CoV2 patients on hemodialysis

康复者血浆疗法对接受血液透析的SARS-CoV-2患者的疗效和安全性

期刊:
影响因子:
doi:10.1111/hdi.12951
Sajmi, Shaji; Goutham, Kamalakannan; Arumugam, Venkatesh; Gopalakrishnan, Natarajan; Lamech, Tanuj Moses; Aiswarya, Dhanapalan; Krishna, Ravindran; Vathsalyan, Paulpandian; Kannan, Badri Srinivasan; Solomon, Dolphin; Nithya, Govindasamy; Sastry, Bhagavatula V R H; Sakthirajan, Ramanathan
SARS-CoV-2
发表日期：2021
文献求助 收藏